{{ (moduleVm.actions && moduleVm.changeStatus) ? moduleVm.status : '' }} The Explosion of a New Designer Drug, Flakka: Implications for Practice

Activity Steps

Purpose of Activity

To provide information on the new designer drug, flakka.

Learning Objectives

After completing this continuing education activity you will be able to:

  1. Identify the pharmacokinetics and the physiological and psychological effects of flakka use.
  2. Examine the treatment of flakka users and the implications for healthcare providers.
  3. Educate your clients about the dangers of experimenting with flakka.
Price: $12.95


  • NAADAC 1.0 CH

Wolters Kluwer Health is a NAADAC-Approved Education Provider. Provider number 110696.

Professions: Addiction Counselor
Test Code: JAN1018AC
Published: Oct/Dec 2018
Expires: 10/31/2022
Required Passing Score: 14/18 (77%)
Authors: Deborah Salani, DNP, PMHNP-BC, APRN, NE-BC; Laura D. Albuja, DNP, APRN, FNP-C; Martin M. Zdanowicz, PhD, MEd, MA
Specialties: Addictions